Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 31, 2024 06:45 ET | Source: BioNTech SE

BioNTech und DualityBio erhalten Fast-Track-Status der FDA für innovativen Antikörper-Wirkstoff-Konjugat-Kandidat BNT325/DB-1305

Der Status basiert auf vorläufigen Daten zur Sicherheit und Wirksamkeit aus einer laufenden Phase-1/2-Studie in Patientinnen mit platinresistentem Epithelkarzinom der Eierstöcke, Eileiter...
January 31, 2024 06:45 ET | Source: BioNTech SE

BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305

Designation is based on preliminary safety and efficacy data from an ongoing Phase 1/2 trial in patients with platinum-resistant ovarian epithelial cancer, fallopian tube, or primary...